| Dr Jennifer Jo Donohue, MD | |
|
4855 Sw Western Ave, Beaverton, OR 97005-3460 | |
| (503) 520-4862 | |
| Not Available |
| Full Name | Dr Jennifer Jo Donohue |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 36 Years |
| Location | 4855 Sw Western Ave, Beaverton, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912912411 | NPI | - | NPPES |
| 073523 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD19527 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
A bill that allows pregnant women to obtain a legal abortion in Mexico City during the first three months' gestation was published into law on Thursday, the AP/Houston Chronicle reports (Castillo, AP/Houston Chronicle , 4/26).
Health and Human Services Secretary Kathleen Sebelius is being called to Capitol Hill by Republican lawmakers who want her to explain what went wrong with the Oct. 1 unveiling of healthcare.gov. She is also facing calls for her resignation. Still, according to Politico, her job is safe.
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell $21.0 million of shares of its Series 5 Preferred Stock in a registered offering to three institutional investors (collectively, the "Initial Purchasers"). Each share of Series 5 Preferred Stock is convertible at the option of the holder, at any time during its existence, into 2,500 shares of common stock at a conversion price of $0.40 per share of common stock, for a total of 52,500,000 shares of common stock.
Ipsen and the US company EpiVax, Inc. today announced that they have completed a collaborative project that provides a novel approach for creating next generation botulinum neurotoxin (BoNT) and Targeted Secretion Inhibitor (TSI) therapeutics.
A study led by SUNY Downstate Medical Center's School of Public Health presents evidence linking personal care products used during pregnancy to adverse reproductive effects in newborns.
› Verified 1 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
A bill that allows pregnant women to obtain a legal abortion in Mexico City during the first three months' gestation was published into law on Thursday, the AP/Houston Chronicle reports (Castillo, AP/Houston Chronicle , 4/26).
Health and Human Services Secretary Kathleen Sebelius is being called to Capitol Hill by Republican lawmakers who want her to explain what went wrong with the Oct. 1 unveiling of healthcare.gov. She is also facing calls for her resignation. Still, according to Politico, her job is safe.
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell $21.0 million of shares of its Series 5 Preferred Stock in a registered offering to three institutional investors (collectively, the "Initial Purchasers"). Each share of Series 5 Preferred Stock is convertible at the option of the holder, at any time during its existence, into 2,500 shares of common stock at a conversion price of $0.40 per share of common stock, for a total of 52,500,000 shares of common stock.
Ipsen and the US company EpiVax, Inc. today announced that they have completed a collaborative project that provides a novel approach for creating next generation botulinum neurotoxin (BoNT) and Targeted Secretion Inhibitor (TSI) therapeutics.
A study led by SUNY Downstate Medical Center's School of Public Health presents evidence linking personal care products used during pregnancy to adverse reproductive effects in newborns.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Jo Donohue, MD 4855 Sw Western Ave, Beaverton, OR 97005-3460 Ph: () - | Dr Jennifer Jo Donohue, MD 4855 Sw Western Ave, Beaverton, OR 97005-3460 Ph: (503) 520-4862 |
News Archive
A bill that allows pregnant women to obtain a legal abortion in Mexico City during the first three months' gestation was published into law on Thursday, the AP/Houston Chronicle reports (Castillo, AP/Houston Chronicle , 4/26).
Health and Human Services Secretary Kathleen Sebelius is being called to Capitol Hill by Republican lawmakers who want her to explain what went wrong with the Oct. 1 unveiling of healthcare.gov. She is also facing calls for her resignation. Still, according to Politico, her job is safe.
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell $21.0 million of shares of its Series 5 Preferred Stock in a registered offering to three institutional investors (collectively, the "Initial Purchasers"). Each share of Series 5 Preferred Stock is convertible at the option of the holder, at any time during its existence, into 2,500 shares of common stock at a conversion price of $0.40 per share of common stock, for a total of 52,500,000 shares of common stock.
Ipsen and the US company EpiVax, Inc. today announced that they have completed a collaborative project that provides a novel approach for creating next generation botulinum neurotoxin (BoNT) and Targeted Secretion Inhibitor (TSI) therapeutics.
A study led by SUNY Downstate Medical Center's School of Public Health presents evidence linking personal care products used during pregnancy to adverse reproductive effects in newborns.
› Verified 1 days ago
Philip W Pritchard, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1881 Nw 185th Ave, Suite 300, Beaverton, OR 97006 Phone: 503-216-9300 Fax: 503-216-9339 | |
David Albert Pierce, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 15950 Sw Millikan Way, Beaverton, OR 97006 Phone: 503-646-0161 Fax: 503-221-4451 | |
Dr. Carolyn Lee Goebel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2935 Sw Cedar Hills Blvd, Beaverton, OR 97005 Phone: 503-352-6000 | |
Dr. Gerald Wendal Miller, M.D, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1960 Nw 167th Place, Suite 103, Beaverton, OR 97006 Phone: 503-466-1823 Fax: 503-466-1823 | |
Dr. Priscilla Butler, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-643-7565 | |
Vicki Lynne Reid, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-520-4863 | |
Vanessa H Mckiel, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2935 Sw Cedar Hills Blvd, Beaverton, OR 97005 Phone: 503-352-6000 |